Eisai Co., Ltd. Annual Report 2001 - Eisai GmbH

More documents

Recommendations

Info

38 Eisai Annual Report 2001 Millions of yen 2000 North Asia Eliminations Japan America Europe and Others (corporate) Consolidated Net sales to customers ¥223,529 ¥64,614 ¥11,541 ¥2,786 ¥302,470 Intersegment sales 23,297 9,394 1,522 208 ¥(34,421) Total net sales 246,826 74,008 13,063 2,994 (34,421) 302,470 All operating expenses 199,737 74,471 14,061 2,903 (25,835) 265,337 Operating income (loss) ¥ 47,089 ¥ (463) ¥ (998) ¥ 91 ¥ (8,586) ¥ 37,133 Assets ¥345,514 ¥55,074 ¥14,095 ¥6,524 ¥(64,467) ¥485,674 (c) Overseas sales for the years ended March 31, 2001 and 2000 were as follows: Millions of yen Thousands of U.S. dollars 2001 2001 North Asia North Asia America Europe and Others Total America Europe and Others Total Overseas sales ¥105,703 ¥19,073 ¥7,305 ¥132,081 $852,444 $153,814 $58,911 $1,065,169 Consolidated sales 361,712 2,917,032 Share of overseas sales 29.2%. 5.3%. 2.0%. 36.5%. Millions of yen 2000 North Asia America Europe and Others Total Overseas sales ¥67,363 ¥16,360 ¥6,621 ¥ 90,344 Consolidated sales 302,470 Share of overseas sales 22.3%. 5.4%. 2.2%. 29.9%. Note 14. Subsequent Events (a) At the General Shareholders’ Meeting held on June 28, 2001, the shareholders of the Company authorized the following appropriations of retained earnings at March 31, 2001. Thousands of Years ending March 31 Millions of yen U.S. dollars Year-end cash dividends ¥13.00 ($0.10) per share ¥3,854 $31,081 Transfer to legal reserve 400 3,226 Bonuses to board of directors 87 702 (b) At the General Shareholders’ Meeting held on June 28, 2001, the Company’s shareholders approved the stock option plan for the Company’s directors and applicable persons. The Company’s seven Board of Directors’ members will be allocated options for a maximum of 62,000 new stocks and 35 other applicable persons in the Company will be allocated options for a maximum of 118,000 new stocks. Such stock option can be exercised from September 3, 2001 to June 28, 2011.
To the Board of Directors and Shareholders of Eisai Co., Ltd. We have examined the consolidated balance sheets of Eisai Co., Ltd. and consolidated subsidiaries as of March 31, 2001 and 2000, and the related consolidated statements of income, shareholders’ equity, and cash flows for the years then ended, all expressed in Japanese yen. Our examinations were made in accordance with auditing standards, procedures and practices generally accepted and applied in Japan and, accordingly, included such tests of the accounting records and such other auditing procedures as we considered necessary in the circumstances. In our opinion, the consolidated financial statements referred to above present fairly the financial position of Eisai Co., Ltd. and consolidated subsidiaries as of March 31, 2001 and 2000, and the results of their operations and their cash flows for the years then ended in conformity with accounting principles and practices generally accepted in Japan applied on a consistent basis. As discussed in Note 2, effective April 1, 2000, the consolidated financial statements have been prepared in accordance with new accounting standards for employees’ retirement benefits and financial instruments. Our examinations also comprehended the translation of Japanese yen amounts into U.S. dollar amounts and, in our opinion, such translation has been made in conformity with the basis stated in Note 1. Such U.S. dollar amounts are presented solely for the convenience of readers outside Japan. Tokyo, Japan June 28, 2001 Independent Auditors’ Report Eisai Annual Report 2001 39
Page 1 and 2: Human Health Care The script for ou
Page 3 and 4: CONSOLIDATED FINANCIAL HIGHLIGHTS E
Page 5 and 6: In Japan, we are proceeding with de
Page 7 and 8: Fiscal 2001 marks the conclusion of
Page 9 and 10: humanity-based sales activities the
Page 11 and 12: Selected Research Candidates (As of
Page 13 and 14: working together to develop antican
Page 15 and 16: REVIEW OF OPERATIONS PHARMACEUTICAL
Page 17 and 18: Consumer Health Care Products The c
Page 19 and 20: REINFORCING OUR RELATIONSHIP WITH S
Page 21 and 22: FINANCIAL SECTION Contents 20 Finan
Page 23: Net Income Current income taxes for
Page 26 and 27: 24 CONSOLIDATED FINANCIAL STATEMENT
Page 28 and 29: 26 Consolidated Statements of Incom
Page 30 and 31: 28 Consolidated Statements of Cash
Page 32 and 33: 30 (e) Property, plant and equipmen
Page 34 and 35: 32 Proceeds from sales of available
Page 36 and 37: 34 Note 7. Retirement and Pension P
Page 38 and 39: 36 III. Actual lease payments, Depr
Page 42 and 43: 40 JAPAN AND OVERSEAS OPERATIONS No
Page 44 and 45: 42 MAJOR PRODUCTS Prescription Phar
Page 46 and 47: 44 CORPORATE INFORMATION (As of Mar

Eisai Co., Ltd. Annual Report 2001 - Eisai GmbH

Create successful ePaper yourself

Delete template?

Save as template?